Search Results for: prostate cancer

The prostate specific antigen (PSA) level and the level of pathologist expertise are key factors in determining whether the Gleason score of a given prostate cancer should be upgraded to indicate higher grade disease, new research suggest.

LabCorp has entered into a license agreement with Veridex LLC to commercialize nucleic acid testing technology for detecting the presence of methylated GST-Pi, a key tissue marker in prostate cancer.

PSA test for prostate cancer should be repeated before biopsy The prostate specific antigen (PSA) blood test is used in routine prostate cancer screening for men over 50, and elevated PSA levels typically result in referral for a prostate biopsy.

While the title of this section is Men’s Health, we’re focusing on prostate cancer since it is the third most common cause of cancer death in American men and the most common cause of death from cancer in men over 75 years old. It affect